These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

555 related items for PubMed ID: 11346913

  • 1. [Dyslipidemia in diabetes mellitus].
    Niemeijer-Kanters SD, Banga JD, Erkelens DW.
    Ned Tijdschr Geneeskd; 2001 Apr 21; 145(16):769-74. PubMed ID: 11346913
    [Abstract] [Full Text] [Related]

  • 2. [Disorders of lipid metabolism in 3 patients with diabetes mellitus type 2].
    Wolffenbuttel BH, Huijberts MS.
    Ned Tijdschr Geneeskd; 2001 Apr 21; 145(16):761-5. PubMed ID: 11346911
    [Abstract] [Full Text] [Related]

  • 3. Lipid-lowering effect of simvastatin in patients of type 2 diabetes mellitus.
    Udawat H, Goyal RK.
    Indian Heart J; 2001 Apr 21; 53(2):172-6. PubMed ID: 11428472
    [Abstract] [Full Text] [Related]

  • 4. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
    Van Ganse E, Laforest L, Burke T, Phatak H, Souchet T.
    Clin Ther; 2007 Aug 21; 29(8):1671-81. PubMed ID: 17919548
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Management of hypercholesterolaemia in the patient with diabetes.
    Packard C, Olsson AG.
    Int J Clin Pract Suppl; 2002 Jul 21; (130):27-32. PubMed ID: 12296606
    [Abstract] [Full Text] [Related]

  • 7. Diabetic dyslipidemia: extending the target beyond LDL cholesterol.
    Nicholls SJ, Lundman P, Tardif JC.
    Eur J Cardiovasc Prev Rehabil; 2010 May 21; 17 Suppl 1():S20-4. PubMed ID: 20489416
    [Abstract] [Full Text] [Related]

  • 8. Reducing cardiovascular risk in diabetes: beyond glycemic and blood pressure control.
    Hobbs FD.
    Int J Cardiol; 2006 Jun 16; 110(2):137-45. PubMed ID: 16289373
    [Abstract] [Full Text] [Related]

  • 9. [Favorable effects of decreasing lipids in patients with diabetes mellitus].
    Gouni-Berthold I, Krone W.
    Dtsch Med Wochenschr; 2006 Dec 16; 131 Suppl 8():S252-4. PubMed ID: 17139581
    [Abstract] [Full Text] [Related]

  • 10. Pharmacologic treatment of type 2 diabetic dyslipidemia.
    Moon YS, Kashyap ML.
    Pharmacotherapy; 2004 Dec 16; 24(12):1692-713. PubMed ID: 15585439
    [Abstract] [Full Text] [Related]

  • 11. Benefits of lipid-lowering therapy in patients with type 2 diabetes mellitus.
    Betteridge J.
    Am J Med; 2005 Dec 16; 118 Suppl 12A():10-5. PubMed ID: 16356802
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Managing dyslipidemia in adults with diabetes.
    Haffner SM.
    Manag Care; 2003 Sep 16; 12(9 Suppl):10-5. PubMed ID: 14535130
    [No Abstract] [Full Text] [Related]

  • 15. [Diabetic dyslipoproteinemia: beyond LDL].
    Merkel M.
    Dtsch Med Wochenschr; 2009 May 16; 134(20):1067-73. PubMed ID: 19421932
    [Abstract] [Full Text] [Related]

  • 16. Lipid disorders in type 2 diabetes.
    Braun LT.
    Nurs Clin North Am; 2001 Jun 16; 36(2):291-302, vii. PubMed ID: 11382564
    [Abstract] [Full Text] [Related]

  • 17. [Lipid-lowering therapy in patients with type-2 diabetes mellitus].
    Pados G, Audikovszky M.
    Orv Hetil; 2003 Mar 23; 144(12):557-61. PubMed ID: 12723526
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Management of dyslipidemia in diabetes.
    Solano MP, Goldberg RB.
    Cardiol Rev; 2006 Mar 23; 14(3):125-35. PubMed ID: 16628021
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.